Rosenberg SA - Search Results

1

A pilot study of the combination of interleukin-2-based immunotherapy and radiation therapy.

Lange JR, Raubitschek AA, Pockaj BA, Spencer WF, Lotze MT, Topalian SL, Yang JC, Rosenberg SA. Lange JR, et al. Among authors: rosenberg sa. J Immunother (1991). 1992 Nov;12(4):265-71. doi: 10.1097/00002371-199211000-00007. J Immunother (1991). 1992. PMID: 1477077 Clinical Trial.

2

Cellular immunotherapy of cancer.

Topalian SL, Rosenberg SA. Topalian SL, et al. Among authors: rosenberg sa. Crit Care Med. 1990 Feb;18(2 Suppl):S144. Crit Care Med. 1990. PMID: 2298029 No abstract available.

3

Pathologic findings associated with interleukin-2-based immunotherapy for cancer: a postmortem study of 19 patients.

Kragel AH, Travis WD, Feinberg L, Pittaluga S, Striker LM, Roberts WC, Lotze MT, Yang JJ, Rosenberg SA. Kragel AH, et al. Among authors: rosenberg sa. Hum Pathol. 1990 May;21(5):493-502. doi: 10.1016/0046-8177(90)90005-p. Hum Pathol. 1990. PMID: 2338330

4

Immunohistochemical correlates of response to recombinant interleukin-2-based immunotherapy in humans.

Rubin JT, Elwood LJ, Rosenberg SA, Lotze MT. Rubin JT, et al. Among authors: rosenberg sa. Cancer Res. 1989 Dec 15;49(24 Pt 1):7086-92. Cancer Res. 1989. PMID: 2582450

5

Experience with the use of high-dose interleukin-2 in the treatment of 652 cancer patients.

Rosenberg SA, Lotze MT, Yang JC, Aebersold PM, Linehan WM, Seipp CA, White DE. Rosenberg SA, et al. Ann Surg. 1989 Oct;210(4):474-84; discussion 484-5. doi: 10.1097/00000658-198910000-00008. Ann Surg. 1989. PMID: 2679456 Free PMC article.

6

Combination therapy with interleukin-2 and alpha-interferon for the treatment of patients with advanced cancer.

Rosenberg SA, Lotze MT, Yang JC, Linehan WM, Seipp C, Calabro S, Karp SE, Sherry RM, Steinberg S, White DE. Rosenberg SA, et al. J Clin Oncol. 1989 Dec;7(12):1863-74. doi: 10.1200/JCO.1989.7.12.1863. J Clin Oncol. 1989. PMID: 2685181 Clinical Trial.

7

Therapy of cancer using the adoptive transfer of activated killer cells and interleukin-2.

Topalian SL, Rosenberg SA. Topalian SL, et al. Among authors: rosenberg sa. Acta Haematol. 1987;78 Suppl 1:75-6. doi: 10.1159/000205907. Acta Haematol. 1987. PMID: 3124451 Clinical Trial.

8

Acute immunologic effects of interleukin-2 therapy in cancer patients: decreased delayed type hypersensitivity response and decreased proliferative response to soluble antigens.

Wiebke EA, Rosenberg SA, Lotze MT. Wiebke EA, et al. Among authors: rosenberg sa. J Clin Oncol. 1988 Sep;6(9):1440-9. doi: 10.1200/JCO.1988.6.9.1440. J Clin Oncol. 1988. PMID: 3262151

9

Interleukin 2 and psoriasis.

Lee RE, Gaspari AA, Lotze MT, Chang AE, Rosenberg SA. Lee RE, et al. Among authors: rosenberg sa. Arch Dermatol. 1988 Dec;124(12):1811-5. Arch Dermatol. 1988. PMID: 3263840

10

Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report.

Rosenberg SA, Packard BS, Aebersold PM, Solomon D, Topalian SL, Toy ST, Simon P, Lotze MT, Yang JC, Seipp CA, et al. Rosenberg SA, et al. N Engl J Med. 1988 Dec 22;319(25):1676-80. doi: 10.1056/NEJM198812223192527. N Engl J Med. 1988. PMID: 3264384

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,359 results

Search Page

Filters